EDDC Discovers Small Molecule Inhibitors For COVID-19 And Other Coronavirus Infections
These compounds target the SARS-CoV-2 main protease and are active against other coronaviruses Lead series of proprietary 3CLpro inhibitors is available for out-licensing or co-development to expedite development and make…
Share